Physician profile
Rizwan Aslam
NPI 1306004460
$6,554.94
in general payments reported to CMS, 2019-2025
15 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,123 · 2020: $256 · 2021: $4,427 · 2022: $141 · 2023: $246 · 2024: $155 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,288.27 | 2021 | |
| Inspire Medical Systems, INC. | $667.96 | 2019-2024 | Inspire |
| Intersect Ent, INC. | $441.34 | 2019-2021 | |
| Aerin Medical INC. | $274.73 | 2023-2025 | |
| Stryker Corporation | $263.26 | 2019-2022 | |
| Medtronic, INC. | $145.23 | 2023-2024 | Propel, Ligasure |
| Optinose US, INC. | $112.53 | 2021 | |
| Cook Medical LLC | $95.48 | 2019 | |
| Cochlear Americas | $77.34 | 2023 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Merck Sharp & Dohme LLC | $68.43 | 2019-2025 | Keytruda |
| Eisai INC. | $40.84 | 2022-2023 | |
| Vantive US Healthcare LLC | $28.31 | 2025 | Renal - Pd |
| Tactile Systems Technology INC | $21.29 | 2024 | Entre Plus, Flexitouch Plus |
| Bioventus LLC | $17.71 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rizwan Aslam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.